METHODS OF TREATING CANCER WITH ANTI-PD-1 ANTIBODIES Application EP-4219563-A2 European Patent Office 02 Aug 2023
Combination therapies for treating cancer with niraparib and PD-1 inhibitors Grant US-11661453-B2 United States of America 30 May 2023
COMBINATION OF CTLA4 AND PD1/PDL1 ANTIBODIES FOR TREATING CANCER Application WO-2022187270-A1 World Intellectual Property Organisation (WIPO) 09 Sep 2022
COMBINATION OF MASKED CTLA4 AND PD1/PDL1 ANTIBODIES FOR TREATING CANCER Application WO-2022187272-A1 World Intellectual Property Organisation (WIPO) 09 Sep 2022
Methods of treating cancer with anti-PD-1 antibodies Grant US-11407830-B2 United States of America 09 Aug 2022
Antibodies directed against programmed death-1 (PD-1) Grant US-11155624-B2 United States of America 26 Oct 2021
ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1) Application EP-3770176-A1 European Patent Office 27 Jan 2021
Antibodies directed against programmed death-1 (PD-1) Grant US-10738117-B2 United States of America 11 Aug 2020
Chemical modulators of immune checkpoints and therapeutic use Grant US-10562864-B2 United States of America 18 Feb 2020
Chemical modulators of immune checkpoints and therapeutic use Application US-10189797-B2 United States of America 29 Jan 2019
METHODS OF TREATING CANCER WITH ANTI-PD-1 ANTIBODIES Application WO-2018129559-A1 World Intellectual Property Organisation (WIPO) 12 Jul 2018
Antibodies directed against programmed death-1 (PD-1) Grant US-9815897-B2 United States of America 14 Nov 2017
PD-1 ANTIBODIES AND USES THEREOF Application WO-2017058115-A1 World Intellectual Property Organisation (WIPO) 06 Apr 2017